These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18951448)

  • 1. Prediction and assessment of splicing alterations: implications for clinical testing.
    Spurdle AB; Couch FJ; Hogervorst FB; Radice P; Sinilnikova OM;
    Hum Mutat; 2008 Nov; 29(11):1304-13. PubMed ID: 18951448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report.
    Agiannitopoulos K; Papadopoulou E; Tsaousis GN; Pepe G; Kampouri S; Kocdor MA; Nasioulas G
    BMC Med Genet; 2019 Jul; 20(1):131. PubMed ID: 31349801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sequence variants of BRCA2 exon 7 alter splicing regulation.
    Gaildrat P; Krieger S; Di Giacomo D; Abdat J; Révillion F; Caputo S; Vaur D; Jamard E; Bohers E; Ledemeney D; Peyrat JP; Houdayer C; Rouleau E; Lidereau R; Frébourg T; Hardouin A; Tosi M; Martins A
    J Med Genet; 2012 Oct; 49(10):609-17. PubMed ID: 22962691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes.
    Théry JC; Krieger S; Gaildrat P; Révillion F; Buisine MP; Killian A; Duponchel C; Rousselin A; Vaur D; Peyrat JP; Berthet P; Frébourg T; Martins A; Hardouin A; Tosi M
    Eur J Hum Genet; 2011 Oct; 19(10):1052-8. PubMed ID: 21673748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico analysis of missense substitutions using sequence-alignment based methods.
    Tavtigian SV; Greenblatt MS; Lesueur F; Byrnes GB;
    Hum Mutat; 2008 Nov; 29(11):1327-36. PubMed ID: 18951440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the change of exon splicing caused by genetic variant using support vector regression.
    Chen K; Lu Y; Zhao H; Yang Y
    Hum Mutat; 2019 Sep; 40(9):1235-1242. PubMed ID: 31070294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary.
    Whiley PJ; Guidugli L; Walker LC; Healey S; Thompson BA; Lakhani SR; Da Silva LM; ; Tavtigian SV; Goldgar DE; Brown MA; Couch FJ; Spurdle AB
    Hum Mutat; 2011 Jun; 32(6):678-87. PubMed ID: 21394826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a 5-tier scheme proposed for classification of sequence variants using bioinformatic and splicing assay data: inter-reviewer variability and promotion of minimum reporting guidelines.
    Walker LC; Whiley PJ; Houdayer C; Hansen TV; Vega A; Santamarina M; Blanco A; Fachal L; Southey MC; Lafferty A; Colombo M; De Vecchi G; Radice P; Spurdle AB;
    Hum Mutat; 2013 Oct; 34(10):1424-31. PubMed ID: 23893897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of computational methods for splice-disrupting variants and improving the performance using the machine learning-based framework.
    Liu H; Dai J; Li K; Sun Y; Wei H; Wang H; Zhao C; Wang DW
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35976049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exon identity influences splicing induced by exonic variants and in silico prediction efficacy.
    Martin N; Bergougnoux A; Baatallah N; Chevalier B; Varilh J; Baux D; Costes B; Fanen P; Raynal C; Sermet-Gaudelus I; Girodon E; Taulan-Cadars M; Hinzpeter A
    J Cyst Fibros; 2021 May; 20(3):464-472. PubMed ID: 33341408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAGI 5 splicing challenge: Improved exon skipping and intron retention predictions with MMSplice.
    Cheng J; Çelik MH; Nguyen TYD; Avsec Ž; Gagneur J
    Hum Mutat; 2019 Sep; 40(9):1243-1251. PubMed ID: 31070280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of semi-quantitative analysis of splicing alterations for the clinical interpretation of variants in BRCA1 and BRCA2 genes.
    Montalban G; Bonache S; Moles-Fernández A; Gadea N; Tenés A; Torres-Esquius S; Carrasco E; Balmaña J; Diez O; Gutiérrez-Enríquez S
    Hum Mutat; 2019 Dec; 40(12):2296-2317. PubMed ID: 31343793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
    Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M
    J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging splice-affecting variant predictors and a minigene validation system to identify Mendelian disease-causing variants among exon-captured variants of uncertain significance.
    Soens ZT; Branch J; Wu S; Yuan Z; Li Y; Li H; Wang K; Xu M; Rajan L; Motta FL; Simões RT; Lopez-Solache I; Ajlan R; Birch DG; Zhao P; Porto FB; Sallum J; Koenekoop RK; Sui R; Chen R
    Hum Mutat; 2017 Nov; 38(11):1521-1533. PubMed ID: 28714225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skipping Nonsense to Maintain Function: The Paradigm of
    Meulemans L; Mesman RLS; Caputo SM; Krieger S; Guillaud-Bataille M; Caux-Moncoutier V; Léone M; Boutry-Kryza N; Sokolowska J; Révillion F; Delnatte C; Tubeuf H; Soukarieh O; Bonnet-Dorion F; Guibert V; Bronner M; Bourdon V; Lizard S; Vilquin P; Privat M; Drouet A; Grout C; Calléja FMGR; Golmard L; Vrieling H; Stoppa-Lyonnet D; Houdayer C; Frebourg T; Vreeswijk MPG; Martins A; Gaildrat P
    Cancer Res; 2020 Apr; 80(7):1374-1386. PubMed ID: 32046981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics.
    Arnold S; Buchanan DD; Barker M; Jaskowski L; Walsh MD; Birney G; Woods MO; Hopper JL; Jenkins MA; Brown MA; Tavtigian SV; Goldgar DE; Young JP; Spurdle AB
    Hum Mutat; 2009 May; 30(5):757-70. PubMed ID: 19267393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary electrophoresis analysis of conventional splicing assays: IARC analytical and clinical classification of 31 BRCA2 genetic variants.
    de Garibay GR; Acedo A; García-Casado Z; Gutiérrez-Enríquez S; Tosar A; Romero A; Garre P; Llort G; Thomassen M; Díez O; Pérez-Segura P; Díaz-Rubio E; Velasco EA; Caldés T; de la Hoya M
    Hum Mutat; 2014 Jan; 35(1):53-7. PubMed ID: 24123850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of a large set of BRCA2 exon 7 variants highlights the predictive value of hexamer scores in detecting alterations of exonic splicing regulatory elements.
    Di Giacomo D; Gaildrat P; Abuli A; Abdat J; Frébourg T; Tosi M; Martins A
    Hum Mutat; 2013 Nov; 34(11):1547-57. PubMed ID: 23983145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events.
    de Jong LC; Cree S; Lattimore V; Wiggins GAR; Spurdle AB; ; Miller A; Kennedy MA; Walker LC
    Breast Cancer Res; 2017 Nov; 19(1):127. PubMed ID: 29183387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
    Plon SE; Eccles DM; Easton D; Foulkes WD; Genuardi M; Greenblatt MS; Hogervorst FB; Hoogerbrugge N; Spurdle AB; Tavtigian SV;
    Hum Mutat; 2008 Nov; 29(11):1282-91. PubMed ID: 18951446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.